Search Results for 'Patients-Nsclc'

Patients-Nsclc published presentations and documents on DocSlides.

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

by stefany-barnette

Renato G. Martins, MD, MPH. Medical Director, Tho...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

by sawyer742

Intervista a Federico . Cappuzzo. Background:. Pr...

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

by everly

Professor Rachel Butler. The genomic complexity of...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

by southan

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Consensus or Controversy?

Consensus or Controversy?

by okelly

Addressing Practical Clinical Questions Across the...

Beth Sandy, MSN, CRNP Nurse Practitioner

Beth Sandy, MSN, CRNP Nurse Practitioner

by PriceOfFreedom

Abramson Cancer Center . University of Pennsylvani...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

by cheryl-pisano

Le Chevalier, . MD. The Role of Translational Res...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

by oconnor

. 5. th. most commonly diagnosed cancer in Austra...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

by elena

Kamil Konopka. Department of Oncology, University ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

by scarlett

NSCLC, non-small cell lung cancer.. Lung cancer in...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

by stefany-barnette

The Cancer genome atlas (TCGA) and the search for...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

by pasty-toler

This program will include a discussion of off-lab...

by jane-oiler

of the expression of . 17-beta-hydroxysteroid . ...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

by test

Intervista a Federico . Cappuzzo. Background:. P...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

by alida-meadow

Gandara. , MD. University of California, Davis . ...

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

by berey

Interview with Shirish M . Gadgeel. , MD . January...

by lorenzo155

4/1/24. Michael Forte, MD. Outline . Lung Cancer ...

INTRODUCTION RESULTS

INTRODUCTION RESULTS

by arjun383

Mason Alford, MSc. a. , . Candace J. Grisham, MS. ...

The Winship Cancer Institute of Emory University

The Winship Cancer Institute of Emory University

by jalin

July 22, 2023. Adjuvant immunotherapy for resectab...

Targeting KRAS G12C in Solid Tumors

Targeting KRAS G12C in Solid Tumors

by morton

: . A . New Anticancer Approach . Marwan Fakih, ...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

by singh

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

by cheryl-pisano

Giorgio V. Scagliotti. University. of . Torino,....

Integration of Immunotherapy Across

Integration of Immunotherapy Across

by pamella-moone

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

by karlyn-bohler

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

by sherrill-nordquist

Colin Reisterer and Nick Swenson. S. . Maheswaran...

Phase II studies of Nivolumab

Phase II studies of Nivolumab

by brianna

in patients with Advanced . Squamous. (SQ) or Non...

The formula Blueprint Medicines (BPMC)

The formula Blueprint Medicines (BPMC)

by erica

The sum of Blueprint’s pieces exceeds current va...

Second line treatments in WT

Second line treatments in WT

by deena

pts. : . which. . opportunities. with . biologic...

New developments in oncological treatment for Stage 3 NSCLC

New developments in oncological treatment for Stage 3 NSCLC

by summer

Lung SSG 22. nd. May 2018. Gareth Ayre. Rationale...

ALK in lung cancer: Past, present, and future

ALK in lung cancer: Past, present, and future

by belinda

Gene Mutations in Lung . Adenocarcinomas. 17 years...